Susquehanna Fundamental Investments, LLC Eton Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.03 $43,388 - $64,445	-21,269 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.43 - $4.69 $25,011 - $34,199	-7,292 Reduced 25.53%	21,269 $93,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $8,355 - $15,044	-2,283 Reduced 7.4%	28,561 $123,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $6.26 $129,544 - $193,083	30,844 New	30,844 $155,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $333M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.